UST-29 version 24

Administrative fees, reimbursements of costs of expert activities, reimbursements of activities associated with the provision of information and reimbursements of other activities 

This guideline supersedes guideline UST-29 version 23 with effect as of 1 June 2023.

Introduction

The guideline is being issued on the basis and in compliance with the provisions of Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts, as amended (hereinafter referred to as the “Act on Pharmaceuticals“), of Act No 48/1997 Coll., on Public Health Insurance and on Amendments to Some Related Acts (hereinafter referred to as the “Act on Public Health Insurance”), of Act No 634/2004 Coll., on Administrative Fees, as amended (hereinafter referred to as the “Act on Administrative Fees“), of Act No 106/1999 Coll., on Free Access to Information, as amended (hereinafter referred to as the “Act on Free Access to Information“), of Act No 257/2001 Coll., on Libraries, as amended (hereinafter referred to as the “Act on Libraries”), of Act No 218/2000 Coll., on Budgetary Rules, as amended (hereinafter referred to as the “Act on Budgetary Rules“), of Act No 375/2022 Coll., on Medical Devices and In Vitro Diagnostic Medical Devices, as amended (hereinafter referred to as the “Act on Devices”), and Act No 167/1998 Coll., on Dependency-Producing Substances and on Amendments to Some Other Acts, as amended (hereinafter referred to as the “Act on Dependency-Producing Substances”).

The Guideline is for recommendation.